155 related articles for article (PubMed ID: 38637427)
1. Clinical impact of whole-body MRI in staging and surveillance of patients with myxoid liposarcoma: a 14-year single-centre retrospective study.
Paruthikunnan S; Gorelik N; Turcotte RE; Jung S; Alcindor T; Powell TI
Eur Radiol; 2024 Apr; ():. PubMed ID: 38637427
[TBL] [Abstract][Full Text] [Related]
2. Early detection of metastases using whole-body MRI for initial staging and routine follow-up of myxoid liposarcoma.
Gorelik N; Reddy SMV; Turcotte RE; Goulding K; Jung S; Alcindor T; Powell TI
Skeletal Radiol; 2018 Mar; 47(3):369-379. PubMed ID: 29275455
[TBL] [Abstract][Full Text] [Related]
3. Whole-body magnetic resonance imaging in myxoid liposarcoma: A useful adjunct for the detection of extra-pulmonary metastatic disease.
Stevenson JD; Watson JJ; Cool P; Cribb GL; Jenkins JP; Leahy M; Gregory JJ
Eur J Surg Oncol; 2016 Apr; 42(4):574-80. PubMed ID: 26831007
[TBL] [Abstract][Full Text] [Related]
4. Staging of neuroendocrine tumours: comparison of [⁶⁸Ga]DOTATOC multiphase PET/CT and whole-body MRI.
Schraml C; Schwenzer NF; Sperling O; Aschoff P; Lichy MP; Müller M; Brendle C; Werner MK; Claussen CD; Pfannenberg C
Cancer Imaging; 2013 Mar; 13(1):63-72. PubMed ID: 23466785
[TBL] [Abstract][Full Text] [Related]
5. [Contribution of whole-body MRI to the initial assessment of myxoid liposarcoma].
Dewaguet J; Beaujot J; Leguillette C; Decanter G; Cordoba A; Penel N; Ceugnart L; Taieb S; Amor MBH
Bull Cancer; 2023 Oct; 110(10):1015-1026. PubMed ID: 37507239
[TBL] [Abstract][Full Text] [Related]
6.
Metser U; Berlin A; Halankar J; Murphy G; Jhaveri KS; Ghai S; Tau N
AJR Am J Roentgenol; 2018 Mar; 210(3):635-640. PubMed ID: 29323548
[TBL] [Abstract][Full Text] [Related]
7. Prospective comparison of the impact on treatment decisions of whole-body magnetic resonance imaging and computed tomography in patients with metastatic malignant melanoma.
Müller-Horvat C; Radny P; Eigentler TK; Schäfer J; Pfannenberg C; Horger M; Khorchidi S; Nägele T; Garbe C; Claussen CD; Schlemmer HP
Eur J Cancer; 2006 Feb; 42(3):342-50. PubMed ID: 16364631
[TBL] [Abstract][Full Text] [Related]
8. Myxoid liposarcoma: local relapse and metastatic pattern in 43 patients.
Dürr HR; Rauh J; Baur-Melnyk A; Knösel T; Lindner L; Roeder F; Jansson V; Klein A
BMC Cancer; 2018 Mar; 18(1):304. PubMed ID: 29558901
[TBL] [Abstract][Full Text] [Related]
9. Distribution and Rate of Myxoid Liposarcoma Spine Metastases: Impact on Surveillance Imaging.
Vierra BM; Saadat LV; Hornick JL; Jagannathan JP; Ferrone ML; Wagner AJ; Wang J; Baldini EH; Raut C; Fairweather M
Ann Surg Oncol; 2023 Dec; 30(13):8647-8652. PubMed ID: 37773566
[TBL] [Abstract][Full Text] [Related]
10. Early detection of multiple bone and extra-skeletal metastases by body magnetic resonance imaging (BMRI) after treatment of Myxoid/Round-Cell Liposarcoma (MRCLS).
Gouin F; Renault A; Bertrand-Vasseur A; Bouilleau L; Crenn V; Rosset P; Tallegas M; Samargandi R; Le Nail LR
Eur J Surg Oncol; 2019 Dec; 45(12):2431-2436. PubMed ID: 31447287
[TBL] [Abstract][Full Text] [Related]
11. Comparison of the diagnostic performance and impact on management of 18F-FDG PET/CT and whole-body MRI in multiple myeloma.
Westerland O; Amlani A; Kelly-Morland C; Fraczek M; Bailey K; Gleeson M; El-Najjar I; Streetly M; Bassett P; Cook GJR; Goh V;
Eur J Nucl Med Mol Imaging; 2021 Jul; 48(8):2558-2565. PubMed ID: 33469686
[TBL] [Abstract][Full Text] [Related]
12. Whole-body MRI with diffusion-weighted sequences compared with 18 FDG PET-CT, CT and superficial lymph node ultrasonography in the staging of advanced cutaneous melanoma: a prospective study.
Jouvet JC; Thomas L; Thomson V; Yanes M; Journe C; Morelec I; Bracoud L; Durupt F; Giammarile F; Berthezene Y
J Eur Acad Dermatol Venereol; 2014 Feb; 28(2):176-85. PubMed ID: 23331931
[TBL] [Abstract][Full Text] [Related]
13. Prognostic factors for the recurrence of myxoid liposarcoma: 20 cases with up to 8 years follow-up.
Lemeur M; Mattei JC; Souteyrand P; Chagnaud C; Curvale G; Rochwerger A
Orthop Traumatol Surg Res; 2015 Feb; 101(1):103-7. PubMed ID: 25583234
[TBL] [Abstract][Full Text] [Related]
14. Supplemental value of diffusion-weighted whole-body imaging with background body signal suppression (DWIBS) technique to whole-body magnetic resonance imaging in detection of bone metastases from thyroid cancer.
Sakurai Y; Kawai H; Iwano S; Ito S; Ogawa H; Naganawa S
J Med Imaging Radiat Oncol; 2013 Jun; 57(3):297-305. PubMed ID: 23721138
[TBL] [Abstract][Full Text] [Related]
15. Can whole-body magnetic resonance imaging with diffusion-weighted imaging replace Tc 99m bone scanning and computed tomography for single-step detection of metastases in patients with high-risk prostate cancer?
Lecouvet FE; El Mouedden J; Collette L; Coche E; Danse E; Jamar F; Machiels JP; Vande Berg B; Omoumi P; Tombal B
Eur Urol; 2012 Jul; 62(1):68-75. PubMed ID: 22366187
[TBL] [Abstract][Full Text] [Related]
16. One-step TNM staging of high-risk prostate cancer using magnetic resonance imaging (MRI): toward an upfront simplified "all-in-one" imaging approach?
Pasoglou V; Larbi A; Collette L; Annet L; Jamar F; Machiels JP; Michoux N; Vande Berg BC; Tombal B; Lecouvet FE
Prostate; 2014 May; 74(5):469-77. PubMed ID: 24375774
[TBL] [Abstract][Full Text] [Related]
17. Does the addition of whole-body MRI to routine imaging influence real-world treatment decisions in metastatic breast cancer?
Bhaludin BN; Tunariu N; Senthivel N; Babiker A; Soneji ND; Hujairi N; Sharma B; McGrath SE; Okines AF; Ring AE; Messiou C; Downey K; Koh DM
Cancer Imaging; 2022 Jun; 22(1):26. PubMed ID: 35672838
[TBL] [Abstract][Full Text] [Related]
18. A Prospective Comparison of
Anttinen M; Ettala O; Malaspina S; Jambor I; Sandell M; Kajander S; Rinta-Kiikka I; Schildt J; Saukko E; Rautio P; Timonen KL; Matikainen T; Noponen T; Saunavaara J; Löyttyniemi E; Taimen P; Kemppainen J; Dean PB; Blanco Sequeiros R; Aronen HJ; Seppänen M; Boström PJ
Eur Urol Oncol; 2021 Aug; 4(4):635-644. PubMed ID: 32675047
[TBL] [Abstract][Full Text] [Related]
19. Feasibility of whole-body MRI for detecting metastatic myxoid liposarcoma: a case series.
Seo SW; Kwon JW; Jang SW; Jang SP; Park YS
Orthopedics; 2011 Nov; 34(11):e748-54. PubMed ID: 22049957
[TBL] [Abstract][Full Text] [Related]
20. Accuracy of whole-body low-dose multidetector CT (WBLDCT) versus skeletal survey in the detection of myelomatous lesions, and correlation of disease distribution with whole-body MRI (WBMRI).
Gleeson TG; Moriarty J; Shortt CP; Gleeson JP; Fitzpatrick P; Byrne B; McHugh J; O'Connell M; O'Gorman P; Eustace SJ
Skeletal Radiol; 2009 Mar; 38(3):225-36. PubMed ID: 19009290
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
